This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n4http://linked.opendata.cz/resource/drugbank/drug/DB08216/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08216/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08216/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08216/identifier/chemspider/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08216/identifier/pdb/

Statements

Subject Item
n2:DB08216
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB08216 n14:DB08216
dcterms:title
2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID
adms:identifier
n4:6323420 n7:99444687 n11:DB08216 n12:MTB n13:22377715
n5:IUPAC-Name
n6:271B42A0-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B42A6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B42A5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B42A2-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B42A3-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B42A4-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B429E-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B429F-363D-11E5-9242-09173F13E4C5 n6:271B429C-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B429D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B42AC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B42AD-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B42A7-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B42A8-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B42AA-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B42A9-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B42AB-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B42B2-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B42B4-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B42B5-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B42B1-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B42B0-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B42B3-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B42A1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B42AE-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B42AF-363D-11E5-9242-09173F13E4C5